Gladstone Institutional Advisory’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$262K Buy
893
+147
+20% +$48.3K 0.01% 720
2025
Q4
$262K Sell
746
-29
-4% -$9.8K 0.01% 677
2025
Q3
$250K Buy
775
+106
+16% +$33K 0.01% 698
2025
Q2
$260K Buy
669
+91
+16% +$36.6K 0.01% 638
2025
Q1
$252K Buy
+578
New +$232K 0.01% 633
2024
Q4
Sell
-564
Closed -$293K 707
2024
Q3
$293K Sell
564
-43
-7% -$23K 0.01% 578
2024
Q2
$329K Sell
607
-416
-41% -$220K 0.02% 516
2024
Q1
$531K Sell
1,023
-149
-13% -$74.1K 0.03% 401
2023
Q4
$553K Buy
1,172
+42
+4% +$19.4K 0.03% 398
2023
Q3
$492K Buy
1,130
+33
+3% +$15K 0.03% 389
2023
Q2
$487K Buy
1,097
+150
+16% +$69.2K 0.03% 401
2023
Q1
$435K Buy
947
+48
+5% +$22.8K 0.03% 438
2022
Q4
$461K Sell
899
-114
-11% -$57.9K 0.03% 418
2022
Q3
$460K Buy
1,013
+47
+5% +$22.5K 0.04% 413
2022
Q2
$466K Sell
966
-149
-13% -$73.7K 0.04% 425
2022
Q1
$548K Sell
1,115
-50
-4% -$22.9K 0.04% 413
2021
Q4
$540K Buy
1,165
+43
+4% +$18.1K 0.04% 367
2021
Q3
$418K Buy
1,122
+51
+5% +$19.4K 0.04% 367
2021
Q2
$409K Buy
1,071
+59
+6% +$22.5K 0.05% 330
2021
Q1
$363K Buy
+1,012
New +$325K 0.06% 289

Other funds holding ELV

Gladstone Institutional Advisory's ELV Position: Q1 2026 in Review

Gladstone Institutional Advisory increased its Elevance Health (ELV) stake by 20% in Q1 2026, buying an estimated $48.3K and bringing the position to 893 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #720.

Gladstone Institutional Advisory first reported a position in ELV in Q1 2021 and has held it in 20 quarters since. The position peaked at $553K in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Gladstone Institutional Advisory held 893 shares of Elevance Health worth $262K as of Q1 2026.
  • Gladstone Institutional Advisory bought 147 Elevance Health shares in Q1 2026, an estimated $48.3K.
  • Elevance Health made up 0.01% of Gladstone Institutional Advisory's portfolio in Q1 2026, its #720 holding.
  • Gladstone Institutional Advisory first reported a position in Elevance Health in Q1 2021 and has held it in 20 quarters since.
  • Gladstone Institutional Advisory's Elevance Health position peaked at $553K in Q4 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.